Metformin directly acts on mitochondria to alter cellular bioenergetics, Cancer & metabolism, vol.2, p.12, 2014. ,
Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria, Biochem J, vol.462, issue.3, pp.475-87, 2014. ,
Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain, Biochem J, vol.348, pp.607-621, 2000. ,
Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I, J Biol Chem, vol.275, issue.1, pp.223-231, 2000. ,
URL : https://hal.archives-ouvertes.fr/inserm-00390049
Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus, N Engl J Med, vol.338, issue.13, pp.867-72, 1998. ,
Metabolic effects of metformin in non-insulindependent diabetes mellitus, N Engl J Med, vol.333, issue.9, pp.550-554, 1995. ,
Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production, Diabetes, vol.43, issue.7, pp.920-928, 1994. ,
The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin, Science, vol.310, issue.5754, pp.1642-1648, 2005. ,
Metformin and reduced risk of cancer in diabetic patients, Bmj, vol.330, issue.7503, p.15849206, 2005. ,
Repositioning metformin for cancer prevention and treatment, Trends in endocrinology and metabolism: TEM, vol.24, issue.9, p.23773243, 2013. ,
DOI : 10.1016/j.tem.2013.05.004
Investigating metformin for cancer prevention and treatment: the end of the beginning. Cancer discovery, vol.2, p.22926251, 2012. ,
Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis, eLife, vol.3, p.2242, 2014. ,
The LKB1-AMPK pathway: metabolism and growth control in tumour suppression, Nat Rev Cancer, vol.9, issue.8, 2009. ,
DOI : 10.1038/nrc2676
URL : http://europepmc.org/articles/pmc2756045?pdf=render
Role of AMP-activated protein kinase in mechanism of metformin action, J Clin Invest, vol.108, issue.8, p.11602624, 2001. ,
The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways, J Biol Chem, vol.277, issue.28, p.11994296, 2002. ,
DOI : 10.1074/jbc.m202489200
URL : http://www.jbc.org/content/277/28/25226.full.pdf
The antidiabetic drug metformin activates the AMPactivated protein kinase cascade via an adenine nucleotide-independent mechanism, Diabetes, vol.51, issue.8, pp.2420-2425, 2002. ,
DOI : 10.2337/diabetes.51.8.2420
URL : http://diabetes.diabetesjournals.org/content/51/8/2420.full.pdf
Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth, Cancer Res, vol.67, issue.14, p.17638885, 2007. ,
Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice, Biochem J, vol.412, issue.2, pp.211-232, 2008. ,
independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner, Cell Metab, vol.11, issue.5, p.20444419, 2010. ,
Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells, Cancer Res, vol.67, issue.22, pp.10804-10816, 2007. ,
Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK, Proc Natl Acad Sci U S A, vol.111, issue.4, pp.435-479, 2014. ,
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells, Cancer Res, vol.66, issue.21, p.17062558, 2006. ,
DOI : 10.1097/01.ogx.0000256746.99250.dd
The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells, Cell Cycle, vol.8, issue.1, p.19106626, 2009. ,
Differential effects of AMPK agonists on cell growth and metabolism, Oncogene, 2014. ,
Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells, Am J Physiol Cell Physiol, vol.292, issue.1, pp.125-161, 2007. ,
AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo, Cell Metab, vol.17, issue.1, p.23274086, 2013. ,
5'-AMP-activated protein kinase (AMPK) is induced by low-oxygen and glucose deprivation conditions found in solid-tumor microenvironments, Mol Cell Biol, vol.26, issue.14, pp.5336-5383, 2006. ,
The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress, Proc Natl Acad Sci U S A, vol.101, issue.10, p.14985505, 2004. ,
Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptordependent mTOR-mediated insulin receptor substrate 1 phosphorylation, Mol Cell Biol, vol.26, issue.1, pp.63-76, 2006. ,
DOI : 10.1128/mcb.26.1.63-76.2006
URL : https://mcb.asm.org/content/26/1/63.full.pdf
mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs, Science, vol.328, issue.5982, p.20508131, 2010. ,
Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolism, Epub 2013/05/21, vol.73, p.23687346, 2013. ,
Reductive carboxylation supports growth in tumour cells with defective mitochondria, Nature, vol.481, issue.7381, pp.385-393, 2012. ,
ATP citrate lyase inhibition can suppress tumor cell growth, Cancer Cell, vol.8, issue.4, p.16226706, 2005. ,
Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of alpha-ketoglutarate to citrate to support cell growth and viability, Proc Natl Acad Sci U S A, vol.108, issue.49, pp.19611-19617, 2011. ,
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia, Nature, vol.481, issue.7381, pp.380-384, 2012. ,
Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity, Proc Natl Acad Sci U S A, vol.107, p.20421486, 2010. ,
An out-of-frame cytochrome b gene deletion from a patient with parkinsonism is associated with impaired complex III assembly and an increase in free radical production, Ann Neurol, vol.48, issue.5, p.11079541, 2000. ,
Quantitative analysis of acetyl-CoA production in hypoxic cancer cells reveals substantial contribution from acetate, Cancer & metabolism, vol.2, 2014. ,
Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides, Nature, vol.508, issue.7494, pp.108-120, 2014. ,
Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annual review of cell and developmental biology, vol.27, pp.441-64, 2011. ,
Brick by brick: metabolism and tumor cell growth, Curr Opin Genet Dev, vol.18, issue.1, pp.54-61, 2008. ,
Mitochondria as biosynthetic factories for cancer proliferation. Cancer & metabolism, vol.3, p.1, 2015. ,
Metformin is synthetically lethal with glucose withdrawal in cancer cells, Cell Cycle, vol.11, issue.15, p.22809961, 2012. ,
mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation, Cell Metab, vol.18, issue.5, 2013. ,
DOI : 10.1016/j.cmet.2013.10.001
URL : https://doi.org/10.1016/j.cmet.2013.10.001
Activation of a metabolic gene regulatory network downstream of mTOR complex 1, Mol Cell, vol.39, issue.2, p.20670887, 2010. ,
LKB1 Inactivation Dictates Therapeutic Response of Non-Small Cell Lung Cancer to the Metabolism Drug Phenformin, Cancer Cell, vol.23, issue.2, p.23352126, 2013. ,
Signaling kinase AMPK activates stress-promoted transcription via histone H2B phosphorylation, Science, vol.329, issue.5996, p.20647423, 2010. ,
DOI : 10.1126/science.1191241
URL : http://europepmc.org/articles/pmc3922052?pdf=render
Deregulated MYC expression induces dependence upon AMPK-related kinase 5, Nature, vol.483, issue.7391, p.22460906, 2012. ,
The biology of cancer: metabolic reprogramming fuels cell growth and proliferation, Cell Metab, vol.7, issue.1, 2008. ,
ATP citrate lyase is an important component of cell growth and transformation, Oncogene, vol.24, issue.41, p.16007201, 2005. ,
Reductive glutamine metabolism is a function of the alpha-ketoglutarate to citrate ratio in cells, Nature communications, vol.4, 2013. ,
Phenformin enhances the therapeutic benefit of BRAF(V600E) inhibition in melanoma, Proc Natl Acad Sci U S A, vol.110, issue.45, pp.18226-18257, 2013. ,
Hypoxic regulation of glutamine metabolism through HIF1 and SIAH2 supports lipid synthesis that is necessary for tumor growth, Cell Metab, vol.19, issue.2, pp.285-92, 2014. ,
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption, Cell Metab, vol.3, issue.3, p.16517406, 2006. ,
HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia, Cell Metab, vol.3, issue.3, p.16517405, 2006. ,
Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug, PLoS One, vol.8, issue.12, p.83832, 2013. ,
AMP-activated protein kinase induces a p53-dependent metabolic checkpoint, Mol Cell, vol.18, issue.3, p.15866171, 2005. ,
Loss of the tumor suppressor LKB1 promotes metabolic reprogramming of cancer cells via HIF-1alpha, Proc Natl Acad Sci U S A, vol.111, issue.7, pp.2554-2563, 2014. ,
PGC-1alpha supports glutamine metabolism in breast cancer, Cancer & metabolism, vol.1, issue.1, p.22, 2013. ,
LKB1 is a central regulator of tumor initiation and pro-growth metabolism in ErbB2-mediated breast cancer, Cancer & metabolism, vol.1, issue.1, 2013. ,
Preparation of lipide extracts from brain tissue, J Biol Chem, vol.191, issue.2, pp.833-874, 1951. ,
Isotopomer spectral analysis of triglyceride fatty acid synthesis in 3T3-L1 cells. The American journal of physiology, vol.263, p.1415685, 1992. ,
INCA: a computational platform for isotopically non-stationary metabolic flux analysis, Bioinformatics, vol.30, issue.9, pp.1333-1338, 2014. ,
Determination of confidence intervals of metabolic fluxes estimated from stable isotope measurements, Metab Eng, vol.8, issue.4, p.16631402, 2006. ,